Another study demonstrated that treatment of chemosensitive neuroblastoma cells with cisplatin reversibly increased EGFR expression and that cisplatin-resistant cells exhibited enhanced EGFR expression dependent of the presence of cisplatin [40]. The gene discussed is EGFR; the disease is neuroblastoma.